129 related articles for article (PubMed ID: 35188303)
1. Magnetic resonance imaging of the normal equine pituitary gland.
Hobbs KJ; Porter E; Wait C; Dark M; MacKay RJ
Vet Radiol Ultrasound; 2022 Jul; 63(4):450-455. PubMed ID: 35188303
[TBL] [Abstract][Full Text] [Related]
2. Age-related Qualitative Histological and Quantitative Stereological Changes in the Equine Pituitary.
Leitenbacher J; Herbach N
J Comp Pathol; 2016; 154(2-3):215-24. PubMed ID: 26810844
[TBL] [Abstract][Full Text] [Related]
3. Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction.
Pease AP; Schott HC; Howey EB; Patterson JS
J Vet Intern Med; 2011; 25(5):1144-51. PubMed ID: 21985144
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
[TBL] [Abstract][Full Text] [Related]
5. Mensuration of the normal pituitary gland from magnetic resonance images in 96 dogs.
Kippenes H; Gavin PR; Kraft SL; Sande RD; Tucker RL
Vet Radiol Ultrasound; 2001; 42(2):130-3. PubMed ID: 11327360
[TBL] [Abstract][Full Text] [Related]
6. Mensuration of the pituitary gland from magnetic resonance images in 17 cats.
Wallack ST; Wisner ER; Feldman EC
Vet Radiol Ultrasound; 2003; 44(3):278-82. PubMed ID: 12816368
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the accuracy of computed tomography for measurement of normal equine pituitary glands.
McKlveen TL; Jones JC; Sponenberg DP; Scarratt K; Ward DL; Aardema CH
Am J Vet Res; 2003 Nov; 64(11):1387-94. PubMed ID: 14620775
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
9. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
Orth DN; Nicholson WE
Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the normal feline pituitary gland in brachycephalic and mesocephalic cats.
Häußler TC; von Pückler KH; Thiel C; Enderlein S; Failing K; Ondreka N; Kramer M; Schmidt MJ
J Feline Med Surg; 2018 Jun; 20(6):578-586. PubMed ID: 28809124
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunohistochemical study of stellate cells in normal canine and equine adenohypophyses and in pituitary tumours.
Méndez A; Martín de las Mulas J; Bautista MJ; Chacón F; Millán Y; Fondevila D; Pumarola M
J Comp Pathol; 1998 Jan; 118(1):29-40. PubMed ID: 9500236
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pituitary cysts in children using modern magnetic resonance imaging techniques.
Mahdi ES; Webb RL; Whitehead MT
Pediatr Radiol; 2019 Dec; 49(13):1781-1787. PubMed ID: 31352514
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the normal equine brain.
Arencibia A; Vazquez JM; Ramirez JA; Ramirez G; Vilar JM; Rivero MA; Alayon S; Gil F
Vet Radiol Ultrasound; 2001; 42(5):405-9. PubMed ID: 11678560
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of the palmar aspect of the equine podotrochlear apparatus: normal appearance.
Busoni V; Snaps F; Trenteseaux J; Dondelinger RF
Vet Radiol Ultrasound; 2004; 45(3):198-204. PubMed ID: 15200255
[TBL] [Abstract][Full Text] [Related]
16. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
Fortin JS; Benskey MJ; Lookingland KJ; Patterson JS; Howey EB; Goudreau JL; Schott HC
BMC Vet Res; 2020 Sep; 16(1):356. PubMed ID: 32977825
[TBL] [Abstract][Full Text] [Related]
17. Agreement in histologic assessments of the pituitary pars intermedia in aged horses.
McFarlane D; Miller LM; Craig LE; Dybdal NO; Habecker PL; Miller MA; Patterson JS; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2055-9. PubMed ID: 16379646
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
Heinrichs M; Baumgärtner W; Capen CC
Vet Pathol; 1990 Nov; 27(6):419-25. PubMed ID: 2177580
[TBL] [Abstract][Full Text] [Related]
20. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction.
McFarlane D; Dybdal N; Donaldson MT; Miller L; Cribb AE
J Neuroendocrinol; 2005 Feb; 17(2):73-80. PubMed ID: 15796757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
